PEN

Penumbra, Inc. (NYSE:PEN) is a California-based medical device company founded in 2004 and publicly traded since September 2015. The company specializes in designing, developing, manufacturing, and marketing innovative medical devices primarily focused on treating blood clots and vascular conditions. Headquartered in Alameda, California, Penumbra has established itself as a leader in thrombectomy technology, which involves the mechanical removal of blood clots from blood vessels. The company operates globally, with the majority of its revenue generated in the United States market, and has been experiencing significant growth driven by its proprietary Computer-Assisted Vacuum Thrombectomy (CAVT) technology platform.